Welcome to LookChem.com Sign In|Join Free
  • or
3-Hydroxytyramine hydrochloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

62-31-7

Post Buying Request

62-31-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

62-31-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 62-31-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 62-31:
(4*6)+(3*2)+(2*3)+(1*1)=37
37 % 10 = 7
So 62-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H

62-31-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A11136)  Dopamine hydrochloride, 99%   

  • 62-31-7

  • 5g

  • 322.0CNY

  • Detail
  • Alfa Aesar

  • (A11136)  Dopamine hydrochloride, 99%   

  • 62-31-7

  • 25g

  • 993.0CNY

  • Detail
  • Alfa Aesar

  • (A11136)  Dopamine hydrochloride, 99%   

  • 62-31-7

  • 100g

  • 3003.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1090)  Dopaminehydrochloride  pharmaceutical secondary standard; traceable to USP, PhEur and BP

  • 62-31-7

  • PHR1090-1G

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (D2960000)  Dopaminehydrochloride  European Pharmacopoeia (EP) Reference Standard

  • 62-31-7

  • D2960000

  • 1,880.19CNY

  • Detail
  • Sigma

  • (H8502)  Dopaminehydrochloride  

  • 62-31-7

  • H8502-5G

  • 375.57CNY

  • Detail
  • Sigma

  • (H8502)  Dopaminehydrochloride  

  • 62-31-7

  • H8502-10G

  • 700.83CNY

  • Detail
  • Sigma

  • (H8502)  Dopaminehydrochloride  

  • 62-31-7

  • H8502-25G

  • 936.00CNY

  • Detail
  • Sigma

  • (H8502)  Dopaminehydrochloride  

  • 62-31-7

  • H8502-100G

  • 3,821.22CNY

  • Detail
  • Cerilliant

  • (D-081)  Dopaminehydrochloridesolution  1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material

  • 62-31-7

  • D-081-1ML

  • 863.46CNY

  • Detail

62-31-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Hydroxytyramine hydrochloride

1.2 Other means of identification

Product number -
Other names 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:62-31-7 SDS

62-31-7Synthetic route

N-(tert-butoxycarbonyl)dopamine
37034-31-4

N-(tert-butoxycarbonyl)dopamine

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
With methanol; chloro-trimethyl-silane for 3h; Reflux;100%
3,4-bis(benzyloxy)-β-nitrostyrene
1699-54-3

3,4-bis(benzyloxy)-β-nitrostyrene

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; hydrogen; palladium on activated charcoal In ethanol under 760 Torr; for 24h; Ambient temperature;99%
2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; acetic acid In water at 160℃; for 6h; Inert atmosphere;98.6%
With hydrogenchloride; water at 100℃; for 144h;76%
With hydrogenchloride; sodium hypophosphite; ion-exchanger Dowex 50 X2-200; hydrogen bromide; isobutyric Acid for 2h; Heating;
Multi-step reaction with 3 steps
1: hydrogen bromide / ethanol / 0.5 h / 50 °C
2: hydrogen bromide / 5 h / 110 - 115 °C / Inert atmosphere
3: hydrogenchloride / isopropyl alcohol / 1 h / 80 °C / Inert atmosphere; Reflux
View Scheme
3-hydroxytyramine hydrobromide
645-31-8

3-hydroxytyramine hydrobromide

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In water; isopropyl alcohol at 70 - 80℃; Inert atmosphere;93%
With hydrogenchloride In isopropyl alcohol at 80℃; for 1h; Solvent; Inert atmosphere; Reflux;90.6%
3-Methoxytyramine hydrochloride
1477-68-5

3-Methoxytyramine hydrochloride

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
Stage #1: 3-Methoxytyramine hydrochloride With hydrogen bromide for 6h; Reflux;
Stage #2: With hydrogenchloride In water
69.81%
C8H11NO2*C7H8N2O*2ClH

C8H11NO2*C7H8N2O*2ClH

A

dopamine hydrochloride
62-31-7

dopamine hydrochloride

B

N-methylnicotinamide hydrochloride
29711-57-7

N-methylnicotinamide hydrochloride

Conditions
ConditionsYield
at 28℃; Equilibrium constant; Thermodynamic data; association enthalpy: ΔH0 (kcal mol-1) = -3.2 (pH=1);
N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine

N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine

A

3,4-dihydroxyphenylacetate
102-32-9

3,4-dihydroxyphenylacetate

B

dopamine hydrochloride
62-31-7

dopamine hydrochloride

C

dopamine-30-sulfate

dopamine-30-sulfate

Conditions
ConditionsYield
at 37℃; pharmacokinetic; concentrations of products in plasma after oral administration of title compound to dogs;
C44H36N4O12P2(2-)*C8H11NO2*H(1+)

C44H36N4O12P2(2-)*C8H11NO2*H(1+)

A

dopamine hydrochloride
62-31-7

dopamine hydrochloride

B

C44H36N4O12P2(2-)

C44H36N4O12P2(2-)

Conditions
ConditionsYield
In d(4)-methanol; water-d2 Equilibrium constant;
3,4-dimethoxyphenylacetonitrile
93-17-4

3,4-dimethoxyphenylacetonitrile

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: diborane / tetrahydrofuran / 16 h / 55 °C / Inert atmosphere
1.2: 0 - 20 °C
2.1: hydrogenchloride; water / 144 h / 100 °C
View Scheme
C23H35NO8

C23H35NO8

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
Stage #1: C23H35NO8 With trifluoroacetic acid In dichloromethane
Stage #2: With hydrogenchloride In methanol; diethyl ether regioselective reaction;
1,2-dimethoxy-4-(2-nitro-vinyl)-benzene
4230-93-7

1,2-dimethoxy-4-(2-nitro-vinyl)-benzene

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: ammonium formate; 5%-palladium/activated carbon / methanol / 60 - 65 °C / Inert atmosphere
2: hydrogen bromide / water / 110 - 120 °C / Inert atmosphere
3: hydrogenchloride / water; isopropyl alcohol / 70 - 80 °C / Inert atmosphere
View Scheme
3,4-dimethoxy-benzaldehyde
120-14-9

3,4-dimethoxy-benzaldehyde

dopamine hydrochloride
62-31-7

dopamine hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: methylamine hydrochloride; triethylamine / ethanol / 20 °C
2: ammonium formate; 5%-palladium/activated carbon / methanol / 60 - 65 °C / Inert atmosphere
3: hydrogen bromide / water / 110 - 120 °C / Inert atmosphere
4: hydrogenchloride / water; isopropyl alcohol / 70 - 80 °C / Inert atmosphere
View Scheme
dopamine hydrochloride
62-31-7

dopamine hydrochloride

3-(3,4-dihydroxyphenyl)propanoic acid pentafluorophenyl ester
169232-24-0

3-(3,4-dihydroxyphenyl)propanoic acid pentafluorophenyl ester

N-(3,4-dihydroxyhydrocinnamoyl)dopamine

N-(3,4-dihydroxyhydrocinnamoyl)dopamine

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 2h;100%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

dopamine hydrochloride
62-31-7

dopamine hydrochloride

N-(tert-butoxycarbonyl)dopamine
37034-31-4

N-(tert-butoxycarbonyl)dopamine

Conditions
ConditionsYield
With sodium hydrogencarbonate In tetrahydrofuran; water at 20℃; for 2h;100%
With sodium hydrogencarbonate In tetrahydrofuran; water at 20℃; for 2h;100%
With triethylamine In methanol99%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

acryloyl chloride
814-68-6

acryloyl chloride

N-[2-(3,4-Dihydroxy-phenyl)-ethyl]acrylamide
201610-44-8

N-[2-(3,4-Dihydroxy-phenyl)-ethyl]acrylamide

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; methanol at 0 - 20℃; for 2h;100%
With triethylamine In tetrahydrofuran; methanol at 20℃; pH=9; Cooling with ice;65%
With triethylamine In tetrahydrofuran; methanol for 1h; Cooling with ice;57%
With borax; sodium hydrogencarbonate; sodium hydroxide In tetrahydrofuran; water at 20℃; for 14h; pH=8; Inert atmosphere;54%
With triethylamine In tetrahydrofuran; methanol at 20℃; for 1h;
dopamine hydrochloride
62-31-7

dopamine hydrochloride

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

ethyl (3,4-dihydroxyphenethyl)carbamate
36205-85-3

ethyl (3,4-dihydroxyphenethyl)carbamate

Conditions
ConditionsYield
Stage #1: dopamine hydrochloride With sodium hydrogencarbonate In tetrahydrofuran; water at 20℃; for 1h;
Stage #2: chloroformic acid ethyl ester In tetrahydrofuran; water at 20℃; for 5h;
100%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

dopamine hydrochloride
62-31-7

dopamine hydrochloride

C23H35NO8

C23H35NO8

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 16h; Inert atmosphere;100%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

2,5-anhydro-D-mannose
495-75-0

2,5-anhydro-D-mannose

1-(α-D-arabinofuranosyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline hydrochloride
87943-09-7, 87984-47-2

1-(α-D-arabinofuranosyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline hydrochloride

Conditions
ConditionsYield
In water for 48h; Ambient temperature;98%
for 48h; Ambient temperature;98%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

3,4-dichlorobenzaldehyde
6287-38-3

3,4-dichlorobenzaldehyde

1-(3,4-Dichloro-phenyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol; hydrochloride

1-(3,4-Dichloro-phenyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol; hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol for 12h; Heating;98%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

stearic acid
57-11-4

stearic acid

N-stearoyldopamine
105955-10-0

N-stearoyldopamine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In tetrahydrofuran Ambient temperature;98%
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine In dichloromethane; ethyl acetate at 0 - 20℃; for 0.5h; Inert atmosphere;35%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine
165749-18-8

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine

Conditions
ConditionsYield
With 1H-imidazole In dichloromethane at 20℃; for 16h; Inert atmosphere;98%
With 1H-imidazole In dichloromethane at 20℃; for 2h;95.8%
With 1H-imidazole In dichloromethane at 20℃; Inert atmosphere;86%
trifluoroacetic acid-methyl ester
431-47-0

trifluoroacetic acid-methyl ester

dopamine hydrochloride
62-31-7

dopamine hydrochloride

N-<2-(3,4-Dihydroxyphenyl)ethyl>trifluoracetamid
65846-04-0

N-<2-(3,4-Dihydroxyphenyl)ethyl>trifluoracetamid

Conditions
ConditionsYield
With triethylamine In methanol at 20℃; Inert atmosphere;98%
With triethylamine In methanol at 20℃;98%
With triethylamine In methanol at 30℃; for 16h;92%
With triethylamine In methanol at 20℃; for 12h;86%
With triethylamine In methanol at 20℃; Sealed tube;82.2%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

4-methyl-1H-imidazole-5-carbaldehyde
68282-53-1

4-methyl-1H-imidazole-5-carbaldehyde

4-(2-(((4-methyl-1H-imidazol-5-yl)methylene)amino)ethyl)benzene-1,2-diol
1363301-25-0

4-(2-(((4-methyl-1H-imidazol-5-yl)methylene)amino)ethyl)benzene-1,2-diol

Conditions
ConditionsYield
Stage #1: dopamine hydrochloride With triethylamine In ethanol for 0.5h;
Stage #2: 4-methyl-1H-imidazole-5-carbaldehyde In ethanol for 4h; Reflux;
98%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

3-methoxy-benzaldehyde
591-31-1

3-methoxy-benzaldehyde

1-(3-Methoxy-phenyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol; hydrochloride

1-(3-Methoxy-phenyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol; hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol for 12h; Heating;97%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

ortho-anisaldehyde
135-02-4

ortho-anisaldehyde

6,7-dihydroxy-1-(2-methoxyphenyl)-1,2,3,4-tetrahydroisoquinolinium chloride

6,7-dihydroxy-1-(2-methoxyphenyl)-1,2,3,4-tetrahydroisoquinolinium chloride

Conditions
ConditionsYield
With hydrogenchloride In methanol for 12h; Heating;97%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

3-(3,5-Dihydroxy-phenyl)-propionic acid pentafluorophenyl ester
188662-00-2

3-(3,5-Dihydroxy-phenyl)-propionic acid pentafluorophenyl ester

3-(3,5-Dihydroxy-phenyl)-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-propionamide

3-(3,5-Dihydroxy-phenyl)-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-propionamide

Conditions
ConditionsYield
With triethylamine In chloroform; N,N-dimethyl-formamide for 2h; Ambient temperature;97%
cis-Octadecenoic acid
112-80-1

cis-Octadecenoic acid

dopamine hydrochloride
62-31-7

dopamine hydrochloride

N-oleoyldopamine
105955-11-1

N-oleoyldopamine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In tetrahydrofuran Ambient temperature;97%
Stage #1: cis-Octadecenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: dopamine hydrochloride In dichloromethane for 12h;
58%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C26H53NO2Si3

C26H53NO2Si3

Conditions
ConditionsYield
With triethylamine In acetonitrile at 0 - 20℃; Inert atmosphere;97%
1-[(2-oxazepan-1-yl)carbonyl]azepan-2-one
19494-73-6

1-[(2-oxazepan-1-yl)carbonyl]azepan-2-one

dopamine hydrochloride
62-31-7

dopamine hydrochloride

N-(3,4-dihydroxyphenethyl)-2-oxoazepane-1-carboxamide

N-(3,4-dihydroxyphenethyl)-2-oxoazepane-1-carboxamide

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 80℃; for 24h; Inert atmosphere;97%
cyclo-[2,6-{CH3N(CH2CH2)2NCH2}2C6H3]2Sb2O2

cyclo-[2,6-{CH3N(CH2CH2)2NCH2}2C6H3]2Sb2O2

dopamine hydrochloride
62-31-7

dopamine hydrochloride

[2,6-{CH3N(CH2CH2)2NCH2}2C6H3Sb(1,2-O2-C6H3-4-(CH2)2NH3)]Cl

[2,6-{CH3N(CH2CH2)2NCH2}2C6H3Sb(1,2-O2-C6H3-4-(CH2)2NH3)]Cl

Conditions
ConditionsYield
In ethanol at 20℃; for 24h;96%
ethylenediaminetetraacetic dianhydride
23911-25-3

ethylenediaminetetraacetic dianhydride

dopamine hydrochloride
62-31-7

dopamine hydrochloride

C26H34N4O10
1357356-94-5

C26H34N4O10

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 70℃; for 18h; Inert atmosphere;95%
linoleic acid
60-33-3

linoleic acid

dopamine hydrochloride
62-31-7

dopamine hydrochloride

(Z,Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-octadeca-9,12-dienamide
105955-12-2

(Z,Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-octadeca-9,12-dienamide

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In tetrahydrofuran Ambient temperature;94%
terephthalic acid
100-21-0

terephthalic acid

dopamine hydrochloride
62-31-7

dopamine hydrochloride

N1,N4-bis(3,4-dihydroxyphenethyl)terephthalamide

N1,N4-bis(3,4-dihydroxyphenethyl)terephthalamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;94%
dopamine hydrochloride
62-31-7

dopamine hydrochloride

C8H7NO2

C8H7NO2

Conditions
ConditionsYield
With sodium hydrogencarbonate; potassium hexacyanoferrate(III) In water at 20 - 68℃; for 2h; Inert atmosphere;93.6%
D-Glyceraldehyde
453-17-8

D-Glyceraldehyde

dopamine hydrochloride
62-31-7

dopamine hydrochloride

(1'S)-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
259183-94-3

(1'S)-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

Conditions
ConditionsYield
In methanol Heating;93%
In methanol 1) RT, overnight, 2) reflux, 2 d;93%
C32H47NO7

C32H47NO7

dopamine hydrochloride
62-31-7

dopamine hydrochloride

C56H74N4O10

C56H74N4O10

Conditions
ConditionsYield
Stage #1: C32H47NO7 With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0℃; for 0.05h;
Stage #2: dopamine hydrochloride In N,N-dimethyl-formamide at 20℃; for 72h;
93%
D-Glucose
2280-44-6

D-Glucose

dopamine hydrochloride
62-31-7

dopamine hydrochloride

6,7-dihydroxy-1-(D-gluco-pentitol-1'-yl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
87943-10-0, 87984-48-3

6,7-dihydroxy-1-(D-gluco-pentitol-1'-yl)-1,2,3,4-tetrahydroisoquinoline hydrochloride

Conditions
ConditionsYield
In water for 48h; Heating;92%
D-glucose
50-99-7

D-glucose

dopamine hydrochloride
62-31-7

dopamine hydrochloride

6,7-dihydroxy-1-(D-gluco-pentitol-1'-yl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
87943-10-0, 87984-48-3

6,7-dihydroxy-1-(D-gluco-pentitol-1'-yl)-1,2,3,4-tetrahydroisoquinoline hydrochloride

Conditions
ConditionsYield
In water for 48h; Heating;92%

62-31-7Relevant academic research and scientific papers

Method for efficiently preparing 5,6-dihydroxyindole (by machine translation)

-

Paragraph 0031-0035, (2020/04/29)

The preparation method 5,6 - of the compound,dihydroxyindole comprises the following steps :(1): dissolving 3,4 - dialkoxybenzylethylamine and a catalyst in an organic solvent, in an organic solvent, carrying out reflux reaction, in the heated stirring state ;(2) and then further purifying to obtain (1)-hydroxyindole solid powder, which is suitable for industrial production, and has a high, product purity, stability, and easy long-term storage after the operation steps, are short ;(3) reaction steps, through an oxidation reaction, and then further purifying the intermediate compound I, and then purifying the compound I by the oxidizing agent, and then purifying the intermediate compound. I by using a, reducing agent, and then, purifying the intermediate compound I by the, oxidation reaction step 5,6 - and further, purifying the obtained dopamine white solid, powder . by oxidation reaction . The method comprises the following steps. (by machine translation)

Synthetic method of high-purity dopamine hydrochloride

-

, (2020/11/23)

The invention provides a synthetic method of dopamine hydrochloride, and belongs to the field of drug synthesis. The preparation method comprises the following steps: taking 3,4-dimethoxyphenylethylamine as an initial raw material, firstly reacting with an acid to form a salt, re-crystallizing and refining to obtain 3,4-dimethoxyphenylethylamine salt, reacting with hydrobromic acid to remove methyl to generate dopamine hydrobromide, and finally reacting with hydrochloric acid to form a salt so as to obtain dopamine hydrochloride. The preparation method provided by the invention has the advantages of cheap and easily available initial raw materials, simple process, no high-temperature and high-pressure hydrogenation step, low cost, high purity and high yield, and is suitable for industrialproduction.

Preparation method of dopamine hydrochloride

-

, (2020/11/26)

The invention provides a method which comprises the following steps: taking veratraldehyde as a starting raw material, firstly carrying out condensation reaction with nitromethane to generate 3, 4-dimethoxy-beta-nitrostyrolene, carrying out catalytic reduction to obtain 3, 4-dimethoxy phenylethylamine, carrying out reaction with hydrobromic acid to remove methoxy, and finally salifying with hydrochloric acid to obtain dopamine hydrochloride. The preparation method has the advantages of cheap and easily available initial raw materials, simple process, no high-temperature and high-pressure steps, low cost, high purity and high yield, and is suitable for industrial production.

Catalytic Strategy for Regioselective Arylethylamine Synthesis

Boyington, Allyson J.,Seath, Ciaran P.,Zearfoss, Avery M.,Xu, Zihao,Jui, Nathan T.

supporting information, p. 4147 - 4153 (2019/03/07)

A mild, modular, and practical catalytic system for the synthesis of the highly privileged phenethylamine pharmacophore is reported. Using a unique combination of organic catalysts to promote the transfer of electrons and hydrogen atoms, this system performs direct hydroarylation of vinyl amine derivatives with a wide range of aryl halides (including aryl chlorides). This general and highly chemoselective protocol delivers a broad range of arylethylamine products with complete regiocontrol. The utility of this process is highlighted by its scalability and the modular synthesis of an array of bioactive small molecules.

Palladium-catalyzed cyanomethylation of aryl halides through domino Suzuki coupling-isoxazole fragmentation

Velcicky, Juraj,Soicke, Arne,Steiner, Roland,Schmalz, Hans-Guenther

supporting information; experimental part, p. 6948 - 6951 (2011/06/19)

A one-pot protocol for the cyanomethylation of aryl halides through a palladium-catalyzed reaction with isoxazole-4-boronic acid pinacol ester was developed. Mechanistically, the reaction proceeds through (1) Suzuki coupling, (2) base-induced fragmentation, and (3) deformylation as shown by characterization of all postulated intermediates. Under optimized conditions (PdCl2dppf, KF, DMSO/H2O, 130 °C) a broad spectrum of aryl bromides could be converted into arylacetonitriles with up to 88% yield.

A new and efficient route for the synthesis of naturally occurring catecholamines

Bernini, Roberta,Crisante, Fernanda,Barontini, Maurizio,Fabrizi, Giancarlo

experimental part, p. 3838 - 3842 (2010/03/30)

Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists, have been prepared by a regioselective oxidation of the corresponding 4-hydroxyphenethylamine derivatives by 2-iodoxybenzoic acid (IBX) in homogeneous as well as in heterogeneous conditions and followed by cleavage of the amino protective group. By using polymer-supported IBX, after the first oxidation, the oxidant can be recovered, regenerated, and efficiently reused for several additional times. An efficient, easy and green procedure for the synthesis of N-(methoxycarbonyl)dopamine, key component of many pharmaceuticals, has also been reported. Georg Thieme Verlag Stuttgart.

Towards synthetic adrenaline receptors - Shape-selective adrenaline recognition in water

Herm, Michael,Molt, Oliver,Schrader, Thomas

, p. 3148 - 3151 (2007/10/03)

A new rationally designed receptor molecule binds adrenaline derivatives in water. Its binding pattern (see picture) imitates the interplay of noncovalent interactions operating in the natural receptor. High shape selectivity is achieved for the slim dopamine skeleton, and leads to rejection of substrates with an a-substituent, such as amino acid derivatives.

Synthesis of Dopamines Labelled with 13C in the α- or β-Side Chain Position and Their Application to Structural Studies on Melanins by Solid-State NMR Spectroscopy

Crescenzi, Orlando,Kroesche, Christoph,Hoffbauer, Wilfried,Jansen, Martin,Napolitano, Alessandra,et al.

, p. 563 - 568 (2007/10/02)

Solid-state NMR spectroscopy was applied to the analysis of melanins prepared by peroxidase-H2O2 oxidation of dopamines specifically 13C labelled in the α- or β-side chain positions.A surprisingly diverse pattern of signals indicated the presence of uncyclized dopamine and noradrenaline-derived units, in addition to indole and carbonyl carbon atoms.These structural features, coupled with the results obtained from elemental analysis of dopamine melanin samples prepared under different conditions, point to a pigment formation process more complex than previously believed. - Key Words: CP-MAS NMR Spectroscopy / Melanin / Oxidative phenolic coupling / Quinone methides / Labelled compounds, 13C / Dopamines / Enzymes

Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs.

Murata,Noda,Kohno,Samejima

, p. 812 - 814 (2007/10/02)

The bioavailability and pharmacokinetics of an oral dopamine prodrug, N-(N-acetyl-L-methionyl)O,O-bis(ethoxycarbonyl)dopamine (1), were examined in dogs, and the mechanism of its absorption and bioactivation was discussed. Compound 1 showed a plasma dopamine concentration that was several times higher than that of dopamine (DA) following oral administration to dogs, while the plasma concentrations of dopamine-30-sulfate (DA-SO4) and 3,4-dihydroxyphenylacetic acid (DOPAC) are lower in comparison with that of DA. The conversion of 1 to DA occurred in proportion to the dose administered. Compound 1 also showed a plasma DA concentration that was several times higher than that of other DA prodrugs reported hitherto. In dog plasma, in vitro, 1 was converted to its deethoxycarbonylated form, N-(N-acetyl-L-methionyl)dopamine (2), while other related compounds, N-(L-methionyl)dopamine (3), N-(L-methionyl)O,O-bis(ethoxycarbonyl)-dopamine (4), and O,O-bis(ethoxycarbonyl)dopamine (5), were rapidly converted to DA (however, 2 was stable in plasma). Bioavailability, based on the AUC of DA, 1, 2, and 5 following oral administration to dogs, increased in the following order: 1, 2, 5, and DA. Thus, it was shown that the two protective groups introduced in 1 served to reduce the first-pass metabolism of the DA moiety in the absorption process. It was also confirmed that 1 is converted to 2 or DA in blood, liver, and intestine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 62-31-7